NSW’s health workers are shunning the AstraZeneca Covid-19 vaccine, Minister Brad Hazzard says, with a “70 to 80 percent” drop in vaccinations since blood clot concerns wer... Read more
Following the booming profit beats of its Wall Street rivals, Credit Suisse is expected to report a significant loss on Thursday as it navigates the fallout from two high-profile crises. The... Read more
8:12 pm: China announces policies to support businesses hit by virus The China Banking and Insurance Regulatory Commission (CBIRC) issued a notice on Saturday urging banks to strengthen loan... Read more
The purported plot of the streaming wars goes as follows: Sick of losing customers and relative market value to Netflix, big media transitioned their aging television-focused businesses to f... Read more
Dogecoin started out as a joke. Now it’s a top 10 digital currency worth $40 billion. The cryptocurrency is based on the “Doge” meme, which rose to popularity in late 2013. The meme portrays... Read more
U.S. stocks climbed to record levels on Thursday after key companies reported strong earnings and fresh economic data pointed to a rebound in consumer spending and the jobs market. The Dow J... Read more
More than two dozen states took steps Tuesday to halt inoculations with Johnson & Johnson’s coronavirus vaccine, shortly after the Food and Drug Administration recommended to pause its u... Read more
The U.K. has eased its lockdown further with the reopening of non-essential shops and perhaps the most keenly-missed social hotspot — pubs — able to welcome customers to their gardens again... Read more
Controversy over AstraZeneca’s Covid-19 vaccine has sparked some investor concerns about its stock, according to Jefferies – but it’s not all bad news for the British pharmaceutical company.... Read more
The British government and health experts in the country have rushed to defend the coronavirus vaccine developed by AstraZeneca and the University of Oxford following concerns over a possibl... Read more
